Clin2
NCT07176286Worth exploringRecruiting

PET scan study for diagnosing Lewy body dementia

Parkinson Disease (PD)Lewy Body Dementia (LBD)

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This trial is testing a special PET scan that uses a radioactive tracer (18F-mFBG) to see how much it is taken up by the heart. The goal is to help tell Lewy body disease (Parkinson's or Lewy body dementia) apart from other brain disorders.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You are either in stable health or have no major changes in your condition for at least 30 days
  • You have a diagnosis of Parkinson's disease or Lewy body dementia, or another brain disorder that is not caused by Lewy body disease
  • You do not have heart disease like a prior heart attack or heart failure
  • You can lie still on your back for up to 20 minutes
  • You are not taking certain medications that can interfere with the scan (your doctor can help check)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04786223Enrolling by invitation· Phase 2
Testing an anti-inflammatory PET imaging treatment in memory loss

This Phase 2 study tests whether targeting “neuroinflammation” (inflammation in the brain) can help in Alzheimer’s disease and related memory disorders. You may help researchers by doing several brain scans (including a special PET/CT scan) along with MRI and amyloid imaging to understand what’s happening in the brain.

Rochester, Minnesota
NCT06120049Recruiting· Phase 2/Phase 3
Comparing new PET scans for Parkinson's, MSA, Lewy body dementia, and Alzheimer's

This study tests if a new radioactive tracer called [18F]-MFBG can help doctors better distinguish between Parkinson's disease, multiple system atrophy (MSA), dementia with Lewy bodies, and Alzheimer's disease. It compares the new scan with two standard scans to see which is most accurate.

Ghent, Gent
NCT06098612Recruiting· Early Phase 1
PET imaging study for Parkinson's and related disorders

This study uses a new PET scan tracer called [11C]SY08 to take pictures of the brain in people with Parkinson's, multiple system atrophy, or dementia with Lewy bodies. It aims to see if this tracer can help better understand and tell apart these conditions.

Charlestown, Massachusetts
NCT06891703Recruiting· Early Phase 1
PET imaging study for Parkinson's and related conditions

This trial uses a new imaging agent (like a dye) to see signs of Parkinson's disease in the brain. If you have Parkinson's or a related condition like Lewy body dementia or multiple system atrophy, this scan may help researchers better understand these illnesses.

Solna
NCT03582488Enrolling by invitation· Phase 4
Tracking brain changes in probable Lewy body dementia

This trial follows people with probable Lewy body dementia over several years to see how the brain changes on MRI and on memory/thinking tests. It may help researchers understand disease progression and improve future care for Lewy body dementia.

Jacksonville, Florida
NCT06289582Recruiting· Early Phase 1
Brain imaging study for Parkinson's disease

This study uses a special PET scan to look at inflammation in the brain of people with Parkinson's disease or those at risk for it. The goal is to better understand the disease and possibly find new ways to track its progression.

Birmingham, Alabama

Hear when a new Parkinson Disease (PD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.